European Journal of Preventive Cardiology
Glucagon-Like Peptide-1-Based Therapies in Cardiovascular Disease: Evidence, Mechanisms, and Emerging Clinical Applications
ReviewInterventions
- Dual gip and GLP-1 receptor agonists
- GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Cardiovascular disease
- Heart failure with preserved ejection fraction
- Humans
The paper
University of Catania
European Journal of Preventive Cardiology, 18 Aug 2026
